Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-5491|32|11|1453-1459

ISSN： 0742-3071

Source： DIABETIC MEDICINE, Vol.32, Iss.11, 2015-11, pp. : 1453-1459

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost‐effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review

By  

DIABETIC MEDICINE, Vol. 32, Iss. 11, 2015-11 ,pp. : 1415-1424

John Wiley & Sons Inc

Access to resources Recommend Favorite

Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus

By  

DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol. 31, Iss. 2, 2015-02 ,pp. : 175-182

John Wiley & Sons Inc

Access to resources Recommend Favorite

An integrative review of the psychosocial facilitators and challenges of continuous subcutaneous insulin infusion therapy in type 1 diabetes

By  

JOURNAL OF ADVANCED NURSING, Vol. 74, Iss. 3, 2018-03 ,pp. : 528-538

John Wiley & Sons Inc

Access to resources Recommend Favorite

One‐year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal‐time insulin: the EDITION 1 12‐month randomized trial, including 6‐month extension

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 9, 2015-09 ,pp. : 835-842

John Wiley & Sons Inc

Access to resources Recommend Favorite

Continuous intraperitoneal insulin infusion in patients with ‘brittle’ diabetes: favourable effects on glycaemic control and hospital stay

By  

DIABETIC MEDICINE, Vol. 19, Iss. 6, 2002-06 ,pp. : 496-501

John Wiley & Sons Inc

Access to resources Recommend Favorite